Blog Archive

Αλέξανδρος Γ. Σφακιανάκης

Thursday, October 28, 2021

Clinical outcome and safety profile of rituximab for the treatment of Dipeptidyl peptidase 4 inhibitors‐induced Bullous pemphigoid

xlomafota13 shared this article with you from Inoreader
View on the web

No comments:

Post a Comment